CORRESP Filing
Can-Fite BioPharma Ltd.
Date: April 1, 2026 · CIK: 0001536196 · Accession: 0001213900-26-038553
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294760
Letter
Can-Fite BioPharma Ltd.
26 Ben Gurion Street
Ramat Gan 5257346 Israel
April 1, 2026
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Can-Fite BioPharma Ltd.
Registration Statement on Form F-3
File No. 333-294760
VIA EDGAR
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Can-Fite BioPharma Ltd. (the “Registrant”) hereby respectfully requests that the effectiveness of the Registration Statement on Form F-3 (File No. 333-294760) of the Registrant (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will be declared effective at 5:00 p.m., Eastern Time, on April 3, 2026 or as soon thereafter as may be practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, LLP, by calling Gary Emmanuel at (212) 801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.
Very truly yours,
CAN-FITE BIOPHARMA LTD.
Show Raw Text
CORRESP
1
filename1.htm
Can-Fite BioPharma Ltd.
26 Ben Gurion Street
Ramat Gan 5257346 Israel
April 1, 2026
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Can-Fite BioPharma Ltd.
Registration Statement on Form F-3
File No. 333-294760
VIA EDGAR
Ladies and Gentlemen:
Pursuant to Rule 461 under the
Securities Act of 1933, as amended, Can-Fite BioPharma Ltd. (the “Registrant”) hereby respectfully requests that the
effectiveness of the Registration Statement on Form F-3 (File No. 333-294760) of the Registrant (the “Registration Statement”)
be accelerated so that the Company’s Registration Statement will be declared effective at 5:00 p.m., Eastern Time, on April 3, 2026
or as soon thereafter as may be practicable.
The undersigned respectfully requests
that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, LLP, by calling
Gary Emmanuel at (212) 801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.
Very truly yours,
CAN-FITE BIOPHARMA LTD.
By:
/s/ Motti Farbstein
Name:
Motti Farbstein
Title:
Chief Executive Officer and
Chief Financial Officer
cc: Gary Emmanuel (Greenberg Traurig, LLP)